Export 255 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
A. Chen, Martz, K., Kershaw, D., Magee, J., and Rao, P. S., “Mortality risk in children after renal allograft failure: a NAPRTCS study.”, Pediatr Nephrol, vol. 25, no. 12, pp. 2517-22, 2010.
G. Chen, Li, J., Ying, Q., Sherman, S., Perkins, N., Sundaram, R., and Mendola, P., “Evaluation of observation-fused regional air quality model results for population air pollution exposure estimation.”, Sci Total Environ, vol. 485-486, pp. 563-574, 2014.
A. Chen, Martz, K., and Rao, P. S., “Does allograft failure impact infection risk on peritoneal dialysis: a North American Pediatric Renal Trials and Collaborative Studies Study.”, Clin J Am Soc Nephrol, vol. 7, no. 1, pp. 153-7, 2012.
H. X. Chen, Mooney, M., Boron, M., Vena, D., Mosby, K., Grochow, L., Jaffe, C., Rubinstein, L., Zwiebel, J., and Kaplan, R. S., “Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.”, J Clin Oncol, vol. 24, no. 21, pp. 3354-60, 2006.
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., Kotloff, K. L., Chua, J. V., Hutter, J., Stephens, I., Stapleton, J., Meier, J., Callahan, S. T., Creech, C. B., Halasa, N. B., Johnston, C., Dolor, R. J., Schmader, K. E., Woods, C. W., and Hill, H., “Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009”, Vaccine, vol. 13, pp. 4240-4248, 2012.
A. Chen, Martz, K., and Rao, P., “Does allograft failure impact school attendance in children? A NAPRTCS study.”, Nephrol Dial Transplant, vol. 27, no. 4, pp. 1682-5, 2012.
M. Chehade, Jones, S. M., Pesek, R. D., A Burks, W., Vickery, B. P., Wood, R. A., Leung, D. Y. M., Furuta, G. T., Fleischer, D. M., Henning, A. K., Dawson, P., Lindblad, R. W., Sicherer, S. H., J Abonia, P., Sherrill, J. D., Sampson, H. A., and Rothenberg, M. E., “Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.”, J Allergy Clin Immunol Pract, vol. 6, no. 5, pp. 1534-1544.e5, 2018.
B. M. Chavers, Sullivan, E. K., Tejani, A., and Harmon, W. E., “Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatr Transplant, vol. 1, no. 1, pp. 22-8, 1997.
J. R. Chang, Koo, E., Agrón, E., Hallak, J., Clemons, T., Azar, D., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.”, Ophthalmology, vol. 118, no. 11, pp. 2113-9, 2011.
J. Chang, Clemons, T., Sangiovanni, J., Agron, E., and Chew, E., “Demographic and Dietary Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Participants and Their Associations With Age-Related Macular Degeneration (AMD)”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2010.
Y. - H. Chang, Duong, D. M., Goll, J. B., Wood, D. C., Jensen, T. L., Yin, L., Gelber, C. E., Seyfried, N. T., Anderson, E., Natrajan, M. S., Rouphael, N., Johnson, R. A., Sanz, P., Mulligan, M. J., and Hoft, D. F., “Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 311 St, “Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial”, Lancet, vol. 384, pp. 2046-2052, 2014.
L. - J. Chang, Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G., Sarwar, U. N., Hu, Z., Enama, M. E., Bailer, R. T., Koup, R. A., Schwartz, R. M., Akahata, W., Nabel, G. J., Mascola, J. R., Pierson, T. C., Graham, B. S., and Ledgerwood, J. E., “Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.”, Lancet, vol. 384, no. 9959, pp. 2046-52, 2014.
K. - C. Chang, Der Wang, J. -, Saxon, A., Matthews, A. G., Woody, G., and Hser, Y. - I., “Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.”, Int J Drug Policy, vol. 43, pp. 1-6, 2017.
C. K. Chan, Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Scott, I. U., Tolentino, M. J., and Blodi, B. A., “SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.”, Ophthalmology, vol. 118, no. 7, pp. 1364-72, 2011.
C. Chan, Ip, M., Van Veldhuisen, P., Oden, N., Scott, I., Tolentino, M., and Blodi, B., “SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion”, Ophthalmology, vol. 118, pp. 1364-1372, 2011.
J. M. Chamberlain, Okada, P., Holsti, M., Mahajan, P., Brown, K. M., Vance, C., Gonzalez, V., Lichenstein, R., Stanley, R., Brousseau, D. C., Grubenhoff, J., Zemek, R., Johnson, D. W., Clemons, T. E., and Baren, J., “Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial.”, JAMA, vol. 311, no. 16, pp. 1652-60, 2014.
J. Chamberlain, Okada, P., Holsti, M., Mahajan, P., Brown, K., Vance, C., Gonzalez, V., Lichenstein, R., Stanley, R., Brousseau, D., Grubenhoff, J., Zemek, R., Johnson, D., Clemons, T., Baren, J., and PECARN), T. Pediatric, “Lorazepam vs Diazepam for Pediatric Status Epilepticus: A Randomized Clinical Trial”, JAMA, vol. 311, pp. 1652-1660, 2014.
S. Chakraborty, Harro, C., DeNearing, B., Brubaker, J., Connor, S., Maier, N., Dally, L., Flores, J., A Bourgeois, L., Walker, R., and Sack, D. A., “Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.”, PLoS Negl Trop Dis, vol. 12, no. 4, p. e0006442, 2018.
S. Chakraborty, Harro, C., DeNearing, B., Bream, J., Bauers, N., Dally, L., Flores, J., Van de Verg, L., Sack, D. A., and Walker, R., “Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.”, Clin Vaccine Immunol, vol. 23, no. 4, pp. 315-25, 2016.
I. Cebere, Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J. E., Darwin, S. C., Fast, P. E., Conlon, C., Rowland-Jones, S., McMichael, A. J., and Hanke, T., “Phase I Clinical Trial Safety of DNA- and Modified Virus Ankara-Vectored Human Immunodeficiency Virus Type 1 (HIV-1) Vaccines Administered Alone and in a Prime-Boost Regime to healthy HIV-1 Uninfected Volunteers”, Vaccine, vol. 24, pp. 417-425, 2006.
I. Cebere, Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J. E., Darwin, S. C., Fast, P. E., Conlon, C., Rowland-Jones, S., McMichael, A. J., and Hanke, T., “Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.”, Vaccine, vol. 24, no. 4, pp. 417-25, 2006.
A. T. Catanzaro, Roederer, M., Koup, R. A., Bailer, R. T., Enama, M. E., Nason, M. C., Martin, J. E., Rucker, S., Andrews, C. A., Gomez, P. L., ,, Nabel, G. J., Graham, B. S., and Team, T. V. R. C. 007 St, “Phase I Clinical Evaluation of a Six-Plasmid Multiclade HIV-1 DNA Candidate Vaccine”, Vaccine, vol. 25, pp. 4085-4092, 2007.
A. T. Catanzaro, Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B., Gall, J., King, C., Andrews, C., Sheets, R., Gomez, P., Mascola, J., Nabel, G., Graham, B., and Team, T. Vaccine Re, “Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector”, J Infect Dis, vol. 194, pp. 1638-1649, 2006.
A. T. Catanzaro, Roederer, M., Koup, R. A., Bailer, R. T., Enama, M. E., Nason, M. C., Martin, J. E., Rucker, S., Andrews, C. A., Gomez, P. L., Mascola, J. R., Nabel, G. J., and Graham, B. S., “Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.”, Vaccine, vol. 25, no. 20, pp. 4085-92, 2007.